arrow
M

Mariarosaria Conte

precision medicine
H指数:27
被引数:2,286

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

UVI5008: the first reversible, non-covalent Bruton’s tyrosine kinase epi-inhibitor for B-cell malignancies

UVI5008:首款用于B细胞恶性肿瘤的Bruton’s tyrosine kinase可逆性非共价表位抑制剂

2026-02-220
OAAI
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis

Mettl16介导的MXD4抑制通过激活MYC-MAX轴促进白血病

2025-09-140
OAAI
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities (vol 39, pg 1902, 2007)
2024-08-010
PRE
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
2024-07-240
OAAI
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation (vol 41, 83, 2022)
2022-04-110
OAAI
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
2022-03-0326
OAAI
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes (vol 10, pg 776, 2009)

选择性II类HDAC抑制剂通过调节HDAC-MEF2复合物的稳定性和活性来损害肌生成 (第10卷,776页,2009页)

2020-11-26139
OA